-
Protease Inhibitor Cocktail: Preserve AD Biomarkers
2026-09-30
Learn how a Protease Inhibitor Cocktail EDTA-Free protects fragile inflammatory biomarkers during extraction and assay preparation. This guide connects protease control with lessons from a recent atopic dermatitis nanofiber hydrogel study and provides a practical, phosphorylation-compatible workflow.
-
Morin C5297 for Reliable Cell Assays
2026-09-30
Morin (SKU C5297) offers a chemically defined, analytically characterized tool for cell viability, mitochondrial, metabolic, and aluminum-ion detection workflows. This scenario-based guide explains how to control solvent effects, interpret mechanism-focused data, and select a reliable Morin source using product specifications and recent podocyte research.
-
HyperScribe™ T7 High Yield RNA Synthesis Kit Guide
2026-09-29
The HyperScribe™ T7 High Yield RNA Synthesis Kit provides a defined research workflow for producing RNA by T7 RNA polymerase transcription, including standard, capped, dye-labeled, or biotinylated transcript workflows when compatible reagents are supplied. It is appropriate for research applications such as RNA interference experiments, RNA structure studies, and RNA vaccine research, but it should not be treated as a diagnostic, clinical manufacturing, or automatically complete capping and labeling system.
-
Bestatin (Ubenimex): Context Is the Mechanism
2026-09-29
Bestatin (Ubenimex) is more than a generic protease inhibitor: its value in translational research depends on matching biochemical selectivity with matrix context, exposure, and orthogonal validation. This thought-leadership guide connects aminopeptidase biology, endothelial invasion, multidrug resistance research, and practical assay design while defining where the evidence remains hypothesis-generating.
-
SB525334: Context-Aware ALK5 Signaling Research
2026-09-28
SB525334 is a selective TGF-beta1 receptor inhibitor for dissecting ALK5–Smad2/3 signaling in fibrosis, renal disease, and tissue repair. This guide develops a context-aware assay strategy based on new bone-transport evidence and clarifies what pathway inhibition can—and cannot—prove.
-
Wnt-C59 and the Wnt Secretion Source Problem
2026-09-28
Wnt-C59 is a potent PORCN inhibitor for investigating whether Wnt-dependent biology relies on ligand production and release. This article uses lithium-engineered exosomal Wnt10a research to show how source-resolved experiments can sharpen interpretation across cancer and bone biology.
-
SU6656 in hiPSC Platelet Research: Assay Design
2026-09-27
Explore how SU6656 can be used as a mechanistic probe in hiPSC-derived megakaryocyte research—not as an assumed ingredient in an optimized platelet protocol. This evidence-focused guide connects Src inhibition to assay design, lineage-stage decisions, and the interpretation of platelet function.
-
Liproxstatin-1: Interpreting Ferroptosis Rescue
2026-09-26
Liproxstatin-1 is a potent ferroptosis inhibitor, but rescue alone does not establish mechanism. This article explains how to pair rescue with lipid-peroxidation measurements and interpret the boundaries between mammalian and fungal ferroptosis research.
-
Protease Inhibitor Cocktail EDTA-Free: K1010
2026-09-25
K1010 helps limit endogenous protease-mediated degradation during protein extraction and sample preparation, with an EDTA-free formulation intended for workflows sensitive to divalent cations. Use it at the stated dilution for lysate-based assays; do not rely on it where EDTA-dependent metalloprotease inhibition is required, and check compatibility with DMSO-sensitive assays.
-
Bestatin Workflows for Aminopeptidase Research
2026-09-25
Bestatin (Ubenimex) lets researchers probe aminopeptidase activity while also supporting cell-based multidrug resistance studies and chemical-genetic experiments in plants. This practical guide separates reported conditions from suggested workflow choices, with controls to help distinguish target inhibition from broader biological effects.
-
BCA Protein Quantification Kit K4102
2026-09-24
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures total protein in low-concentration biochemical samples, including many detergent-containing preparations. Use it for research workflows such as sample normalization, not for diagnostic, clinical, or medical testing.
-
Ivermectin: Assay Workflows for Parasitology Research
2026-09-24
Build reproducible parasite motility and viability assays with Ivermectin, a broad-spectrum anti-parasitic agent whose solvent behavior makes stock preparation and vehicle controls central to experimental design. This guide also separates established parasitology applications from a pancreatic cancer study that offers useful assay-design lessons—but no evidence for an ivermectin–GSDMC connection.
-
Pazopanib: From Kinase Blockade to Assay Design
2026-09-23
Pazopanib (GW-786034) inhibits multiple receptor tyrosine kinases, but its effects depend on the biological context being tested. This article connects its vascular signaling profile with ATRX-stratified glioma research and offers a practical framework for interpreting assays without overstating the evidence.
-
ABT-263 (Navitoclax): Reliable Apoptosis Assays
2026-09-23
This scenario-based guide explains how ABT-263 (Navitoclax), SKU A3007, can support mechanistic viability and apoptosis experiments. It covers solvent handling, assay compatibility, mitochondrial biology, orthogonal validation, interpretation, and practical vendor-selection criteria for cancer biology laboratories.
-
L-Ornithine: From Urea Cycle to Liver–Brain Insight
2026-09-22
L-Ornithine is more than a urea-cycle metabolite: it is a practical probe for connecting hepatic nitrogen disposal with astrocyte energy metabolism. This article translates recent OTC–ornithine–ZBTB7A findings into rigorous experimental strategy, product-selection guidance, and a forward-looking translational framework.